Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Friday
Sep 03rd
Home arrow Farmavita.Net Journal arrow SEMISOLID DOSAGE FORM
SEMISOLID DOSAGE FORM Print E-mail
Written by Sanjay J Daharwal   
Article Index
SEMISOLID DOSAGE FORM
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7

c.)        CHEMICAL MEANS:                                                 

Carbopol polymers are polymers of acrylic acid cross-linked with polyalkenyl ethers or divinyl glycol. They are produced from primary polymer particles of about 0.2 to 6.0 micron average diameter. The flocculated agglomerates cannot be broken into the ultimate particles when produced. Each particle can be viewed as a network structure of polymer chains interconnected via cross-linking.  Carbomers were first prepared and patented in 1957. Since then, a number of extended release tablet formulations, which involve carbomer matrices, have been patented. Carbomers readily absorb water, get hydrated and swell. In addition to its hydrophilic nature, its cross-linked structure and its essentially insolubility in water makes Carbopol a potential candidate for use in controlled release drug delivery system. Carbopol polymers are manufactured by cross-linking process. Depending upon the degree of cross-linking and manufacturing conditions, various grades of Carbopol are available. Each grade is having its significance for its usefulness in pharmaceutical dosage forms Polymers produced in co solvent (a cyclohexane / ethyl acetate mixture) have a bulk density of 176 kg/m3 (11 lbs/ft3). Polymers produced in ethyl acetate have an ash content (as potassium sulfate) of 1-3% on average.  

Conclusion: Semisolids constitute a significant proportion of pharmaceutical dosage forms. It has their peculiar theological behavior; semisolids can adhere to the application surface for sufficiently long periods before they are washed off. The novel approaches discussed were applicable for transdermal delivery of pharmaceuticals.

 

 

Comments
Search RSS
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!


 
< Prev   Next >
Advertisement
 

Featured Partners

2010_pharmaci_banner_150x150.gif
jfbals88_banner_150x150_2.gif
bals89_150x150.gif
150x150_g-2.gif 
  dbls02_150x150banner.gif
150x150.gif
evolution_2010_150x150.gif
150x150_chronic10_master.gif
150x150_riskshna10_master.gif
dbls03_150x150_anim.gif
banner150_pm2010.gif
bals91_150x150_anim.gif

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 77 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

bals90_150x150_anim.gif  

Reports

rbhc0264_privatehealthcare.gif 

Events

  chc197_150x150.gif

REPORTS

farmavita_research-store.gif